Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Novavax Inc. Stock

Price
Target price
€13.04

€13.04

7.330%
0.89
7.330%
€49.80
 
08:54 / Tradegate WKN: A2PKMZ / Symbol: NVAX / Name: Novavax / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Novavax Inc. in the next few years
Wizard

Novavax Inc. Stock

Novavax Inc. dominated the market today, gaining €0.89 (7.330%).
With 6 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 13.04 € the target price of 49 € shows a potential of 275.82% for Novavax Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Novavax Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Non-cyclic/Cyclic" there were negative voices in the community.
What does Novavax do?

Pros and Cons of Novavax Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Novavax Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Novavax Inc. 7.330% 175.059% 201.626% 55.823% 172.072% -87.763% 85.749%
Ardelyx Inc. 2.910% -12.617% 12.153% 87.355% 28.685% 32.821% -
Evolus Inc -1.690% -4.918% 4.505% 26.087% 28.177% 71.852% -
Salarius Pharmaceuticals Inc. -2.300% -0.469% 3.922% -61.802% -23.604% -98.261% -99.992%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-30

General Impression

The financials of Novavax, a Biotechnology & Medical Research company with US symbol NVAX, paint a mixed picture. Over the past few years, the company has reported a significant increase in its revenue and total assets. However, its net income has consistently been in the negative, and it has faced challenges in maintaining a positive net working capital and managing its liabilities.

Detailed Analysis

Show more

Comments

Prediction Buy
Perf. (%) 44.45%
Target price 17.592
Change
Ends at 13.05.25

Novavax, Inc. (NASDAQ: NVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
Show more

HC Wainwright 
0
Report Share
13.05.24

Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating.
Ratings data for NVAX provided by MarketBeat
Show more

B. Riley 
0
Report Share
09.08.23 Buy 81.31%

Novavax, Inc. (NASDAQ: NVAX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for NVAX provided by MarketBeat
Show more

StockNews.com 
0
Report Share
24.06.23 Sell 98.43%
Show more
Not a member yet? Sign up for free!

News

Why Novavax Stock More Than Doubled Today: https://g.foolcdn.com/editorial/images/776909/break-through-ceiling.jpg
Why Novavax Stock More Than Doubled Today

Shares of Novavax (NASDAQ: NVAX) are up 12% as of midday Friday following the release of the drugmaker's first-quarter results. It's not the report, however, driving the bulk of today's oversize

TheMotleyFool 
0 10.05.24
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole: https://g.foolcdn.com/editorial/images/774362/doctor-vaccinating-a-patient.jpg
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole

The market isn't rational always and everywhere. Sometimes, shares of excellent companies with bright futures almost inexplicably fail to keep pace with broader equities. When that happens, it's

TheMotleyFool 
0 29.04.24
Better Buy: Bluebird Bio Vs. Novavax: https://g.foolcdn.com/editorial/images/772574/physician-giving-a-high-five-to-a-young-patient.jpg
Better Buy: Bluebird Bio Vs. Novavax

If there is one thing Bluebird Bio (NASDAQ: BLUE) and Novavax (NASDAQ: NVAX) have in common, other than their belonging to the biotech industry, it is that both have seen their shares drop

TheMotleyFool 
0 13.04.24